Enterprise Fund backs liver technology (08 Feb 2011)
The Royal Society Enterprise Fund has participated in a £2.75m funding round for OrganOx Ltd which is developing a medical device that will significantly increase the number of human livers available for transplant.
Royal Society invests further in Novacem (28 Jan 2011)
The Royal Society Enterprise Fund announced this week that it has participated in a £1.6m funding round for Novacem, a company developing carbon negative cement.
Miniature droplet technology receives Royal Society Enterprise Fund backing (18 Nov 2010)
The Royal Society Enterprise Fund has led an investment syndicate backing Cambridge-based company, Sphere Fluidics. The University of Cambridge spin-out is working on miniature droplet technology which will allow for the rapid identification, analysis and separation of single cells and molecules.
Device to revolutionise the production of alternative fuels wins the Brian Mercer Award for Innovation 2010 (15 Oct 2010)
Professor Will Zimmerman from the University of Sheffield was awarded the Royal Society’s Brian Mercer Award for Innovation 2010 in recognition of his breakthrough work which promises to revolutionise the production of alternative renewable fuels.
Lafarge participates in Novacem’s Green cement Bond (14 July 2010)
Novacem, the carbon negative cement company, announced the first closing of its Green Cement Bond, together with the participation of Lafarge, the world leader in building materials, as the first subscriber.
Royal Society Enterprise Fund makes further two investments (10 Feb 2010)
The Enterprise Fund has taken significant stakes in Base4Innovation Ltd. which is developing a new generation of ultra-fast DNA sequencing technology, and in ‘green’ air filtration company, Nano-Porous Solutions Ltd. (n-psl).
Royal Society Enterprise Fund announces first investment (06 Aug 2009)
Novacem, a start-up company developing green cement systems, has raised more than £1 million equity from a syndicate comprising The Royal Society Enterprise Fund, Imperial Innovations Group plc and the London Technology Fund.